Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study

Low n-3 polyunsaturated fatty acid (PUFA) status may be associated with neuro-degenerative disorders, in particular Alzheimer's disease, which has been associated with poor dietary fish or n-3 PUFA intake, and low docosahexaenoic acid (DHA) status. The present case–control study used an established biomarker of n-3 PUFA intake (serum cholesteryl ester-fatty acid composition) to determine n-3 PUFA status in patients with Alzheimer's disease, who were free-living in the community. All cases fulfilled the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association criteria for Alzheimer's disease. Detailed neuropsychological testing and neuroimaging established the diagnosis in all cases. The subjects (119 females and twenty-nine males) aged 76·5 (SD 6·6) YEARS HAD A CLINICAL DEMENTIA RATING (CDR) OF 1 (sd 0·62) and a mini mental state examination (MMSE) score of 19·5 (sd 4·8). The control subjects (thirty-six females and nine males) aged 70 (sd 6·0) years were not cognitively impaired (defined as MMSE score <24): they had a mean MMSE score of 28·9 (sd 1·1). Serum cholesteryl ester-eicosapentaenoic acid and DHA levels were significantly lower (P<0·05 and P<0·001 respectively) in all MMSE score quartiles of patients with Alzheimer's disease compared with control values. Serum cholesteryl ester-DHA levels were progressively reduced with severity of clinical dementia. DHA levels did not differ in patients with Alzheimer's disease across age quartiles: all were consistently lower than in control subjects. Step-wise multiple regression analysis showed that cholesteryl ester-DHA and total saturated fatty acid levels were the important determinants of MMSE score and CDR. It remains to be determined whether low DHA status in Alzheimer's disease is a casual factor in the pathogenesis and progression of Alzheimer's disease.

[1]  N. Sheard.  Fish consumption and risk of sudden cardiac death. , 2009, Nutrition reviews.

[2]  W. Connor,et al.  n-3 fatty acids in the brain and retina: evidence for their essentiality. , 2009, Nutrition reviews.

[3]  M. Rowan,et al.  Endogenous sex hormone levels in postmenopausal women with Alzheimer's disease. , 2001, The Journal of clinical endocrinology and metabolism.

[4]  B. Vellas,et al.  Alzheimer disease: protective factors. , 2000, The American journal of clinical nutrition.

[5]  C. Léger,et al.  Differences between polyunsaturated fatty acid status of non-institutionalised elderly women and younger controls: a bioconversion defect can be suspected , 1999, European Journal of Clinical Nutrition.

[6]  J. Calabrese,et al.  Fish oils and bipolar disorder: a promising but untested treatment. , 1999, Archives of general psychiatry.

[7]  G. Roth,et al.  The role of peroxisomes in aging , 1998, Cellular and Molecular Life Sciences CMLS.

[8]  J. Hibbeln.  Fish consumption and major depression , 1998, The Lancet.

[9]  H C Hendrie,et al.  Epidemiology of dementia and Alzheimer's disease. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[10]  J. Deslypere,et al.  Pro‐ and anti‐inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year , 1997, European journal of clinical investigation.

[11]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[12]  V. Rastogi,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.

[13]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[14]  B. Lawlor,et al.  A memory clinic for the assessment of mild dementia. , 1996, Irish medical journal.

[15]  J. Neuhaus,et al.  Serum fatty acids and the risk of coronary heart disease. , 1995, American journal of epidemiology.

[16]  H. Sprecher,et al.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. , 1991, The Journal of biological chemistry.

[17]  T. Koepsell,et al.  A case‐control study of Alzheimer's disease , 1990, Annals of neurology.

[18]  R. Peers.  Alzheimer's disease and omega‐3 fatty acids: hypothesis , 1990, The Medical journal of Australia.

[19]  Anthony F Jorm,et al.  A case‐control study of Alzheimer's disease in Australia , 1990, Neurology.

[20]  T. Nakada,et al.  Membrane fatty acid composition shows δ-6-desaturase abnormalities in Alzheimer's disease , 1990 .

[21]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[22]  M. Katan,et al.  Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. , 1989, The American journal of clinical nutrition.

[23]  F. Cerra,et al.  Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. , 1988, Surgery.

[24]  M. Gibney,et al.  The effect of a dietary supplement of n-3 polyunsaturated fat on platelet lipid composition, platelet function and platelet plasma membrane fluidity in healthy volunteers , 1988, British Journal of Nutrition.

[25]  Anthony F. Jorm,et al.  The prevalence of dementia: A quantitative integration of the literature , 1987, Acta psychiatrica Scandinavica.

[26]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[27]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[28]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[29]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[30]  J. Dyerberg,et al.  Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. , 1971, Lancet.

[31]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[32]  A. Compston.  Brain repair: an overview , 1994, Journal of Neurology.

[33]  W. Markesbery,et al.  Regional Membrane Phospholipid Alterations in Alzheimer's Disease , 2004, Neurochemical Research.

[34]  A. Stoll,et al.  Omega 3 Fatty Acids in Bipolar Disorder A Preliminary Double-blind, Placebo-Controlled Trial , 1999 .

[35]  E. Feskens,et al.  Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.

[36]  D. Mostofsky,et al.  Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. , 1996, The International journal of neuroscience.

[37]  E. Mantzioris,et al.  The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. , 1996, The American journal of clinical nutrition.

[38]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[39]  T. Nakada,et al.  Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease. , 1990, Neuroreport.

[40]  T. Nikkari.  Serum fatty acids and coronary heart disease in Finnish populations. , 1986, Progress in lipid research.

[41]  B. Reisberg,et al.  Clinical Assessment of Cognitive Decline in Normal Aging and Primary Degenerative Dementia: Concordant Ordinal Measures , 1985 .